Sustained high expression of Fcγ receptorII (CD32) on dendritic cells (DCs) in patients with rheumatoid arthritis (RA)
Main Authors: | Radstake, TRDJ, Blom, A, van Gorselen, E, Engelen, L, Adema, G, van Lent, P, Barrera, P, Figdor, C, van den Berg, W |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2002
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273133/ |
Similar Items
-
Increased FcγRII and III expression in synovium and on monocyte derived macrophages of RA-patients results in altered function after immune complex stimulation
by: Blom, AB, et al.
Published: (2002) -
Fcγ receptor targeting in RA
by: Takai, Toshiyuki, et al.
Published: (2012) -
Activating FcγRIII determines cartilage destruction during immune complex arthritis but not in the presence of T-cell immunity
by: van Lent, PLEM, et al.
Published: (2002) -
HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy
by: Zizzari, Ilaria Grazia, et al.
Published: (2011) -
Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after FcγRII-mediated uptake
by: Benitez-Ribas, Daniel, et al.
Published: (2006)